Literature DB >> 10443957

Hereditary and acquired antithrombin deficiency.

H Vinazzer1.   

Abstract

Antithrombin (AT) is the most important inhibitor of activated coagulation enzymes. Deficiency of this protein can be a congenital defect. Different types have been described with a diminution of the entire molecule as well as diminution of activity only with normal concentration and normal activity and concentration but with a decreased sensitivity to heparin. There exist also different types of acquired deficiency due to a diminished production, an increased loss or an increased consumption of the inhibitor. Because AT deficiency is the cause of an increased thrombotic tendency in many cases the therapeutic and prophylactic possibilities are described. Since highly purified concentrates became available, substitution was attempted in cases of AT deficiency. It was found to be of greatest importance in cases of disseminated intravascular coagulation (DIC) which is a frequent consequence of septic or traumatic shock. In such cases an adequate AT-substitution can even be lifesaving as could be shown in different trials.

Entities:  

Mesh:

Year:  1999        PMID: 10443957     DOI: 10.1055/s-2007-994929

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  3 in total

1.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

2.  New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation.

Authors:  Po-An Hu; Sz-Han Wang; Chia-Hui Chen; Bei-Chia Guo; Jenq-Wen Huang; Tzong-Shyuan Lee
Journal:  Nutrients       Date:  2022-06-01       Impact factor: 6.706

3.  Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors.

Authors:  Takumi Tsuchida; Mineji Hayakawa; Shota Kawahara; Osamu Kumano
Journal:  Thromb J       Date:  2022-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.